German antibody specialist YUMAB GmbH has inked a collaboration agreement with Japanese MOLCURE Inc aimed at using the company’s zero-shot AI technology for antibody discovery.
https://european-biotechnology.com/wp-content/uploads/2024/10/Molcure-e1729083269678.png8451506Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-10-16 14:55:562024-10-16 14:55:56Antibody developer Yumab partners with Japanese AI specialist Molcure